Paola Cassoni Selected Research

Anus Neoplasms (Anal Cancer)

5/2021	Concurrent Chemoradiation in Anal Cancer Patients Delivered with Bone Marrow-Sparing IMRT: Final Results of a Prospective Phase II Trial.
1/2019	Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier).
9/2018	Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study.
6/2018	Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer.
5/2018	The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer.
4/2017	Hematologic toxicity in anal cancer patients during combined chemo-radiation: a radiation oncologist perspective.
12/2016	Lumbar-sacral bone marrow dose modeling for acute hematological toxicity in anal cancer patients treated with concurrent chemo-radiation.
7/2016	Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients.
4/2016	Locally Advanced (T3-T4 or N+) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.
4/2016	Early-stage Node-negative (T1-T2N0) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paola Cassoni Research Topics

Disease

57	Neoplasms (Cancer) 12/2021 - 02/2002
15	Glioma (Gliomas) 01/2020 - 05/2007
15	Breast Neoplasms (Breast Cancer) 01/2020 - 08/2002
14	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2006
12	Anus Neoplasms (Anal Cancer) 05/2021 - 07/2015
11	Glioblastoma (Glioblastoma Multiforme) 06/2021 - 04/2009
9	Brain Neoplasms (Brain Tumor) 05/2020 - 05/2007
8	Carcinoma (Carcinomatosis) 09/2019 - 02/2002
7	Colorectal Neoplasms (Colorectal Cancer) 07/2017 - 01/2008
6	Melanoma (Melanoma, Malignant) 01/2021 - 01/2017
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 05/2018
5	Prostatic Neoplasms (Prostate Cancer) 10/2019 - 02/2004
5	Oligodendroglioma 10/2019 - 05/2007
4	Astrocytoma (Pilocytic Astrocytoma) 01/2017 - 04/2009
4	Rectal Neoplasms (Rectal Cancer) 06/2015 - 01/2013
3	Lung Neoplasms (Lung Cancer) 01/2021 - 10/2015
3	Lymphoma (Lymphomas) 01/2021 - 03/2012
3	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2017 - 06/2009
3	Colonic Neoplasms (Colon Cancer) 05/2016 - 04/2009
3	Meningioma (Meningiomas) 05/2015 - 05/2007
2	COVID-19 03/2022 - 10/2021
2	Hyperplasia 01/2021 - 02/2004
2	Adenocarcinoma of Lung 01/2021 - 02/2017
2	Ovarian Neoplasms (Ovarian Cancer) 05/2020 - 06/2017
2	Carcinoid Tumor (Carcinoid) 09/2019 - 01/2008
2	Adenocarcinoma 09/2019 - 01/2018
2	Inflammation (Inflammations) 01/2019 - 10/2003
2	Ependymoma 02/2016 - 02/2011
2	Endometriosis 04/2014 - 12/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2009 - 01/2008
2	Kaposi Sarcoma (Kaposi's Sarcoma) 02/2004 - 04/2002
1	Infections 03/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Amyloidosis 01/2021
1	Synovial Sarcoma (Synovioma) 01/2021
1	Hemangiosarcoma (Angiosarcoma) 01/2021
1	Fibroma (Fibromatosis) 01/2021
1	Fasciitis (Fascitis) 01/2021
1	Aggressive Fibromatosis (Desmoid) 01/2021
1	Pleurisy (Pleuritis) 01/2021

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2003
9	Caveolin 1IBA 02/2017 - 05/2007
8	Messenger RNA (mRNA)IBA 01/2016 - 02/2002
7	Temozolomide (Temodar)FDA LinkGeneric 12/2019 - 04/2011
6	Biological ProductsIBA 01/2020 - 04/2002
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 02/2004
6	Estrogen ReceptorsIBA 06/2017 - 10/2003
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2014
5	Androgen Receptors (Androgen Receptor)IBA 08/2020 - 06/2017
5	ParaffinIBA 01/2020 - 04/2014
4	Formaldehyde (Formol)FDA Link 01/2020 - 10/2014
4	GhrelinIBA 08/2009 - 02/2003
4	Oxytocin (Pitocin)FDA LinkGeneric 06/2006 - 04/2002
3	Trastuzumab (Herceptin)FDA Link 01/2021 - 02/2013
3	Bevacizumab (Avastin)FDA Link 04/2020 - 02/2014
3	AntigensIBA 01/2020 - 01/2011
3	Estrogens (Estrogen)FDA Link 01/2020 - 08/2002
3	ErbB Receptors (EGF Receptor)IBA 06/2017 - 06/2009
3	LigandsIBA 11/2012 - 01/2007
3	Hormones (Hormone)IBA 11/2011 - 04/2006
3	Ghrelin ReceptorsIBA 02/2004 - 02/2002
2	xylometazoline (stas)IBA 01/2021 - 09/2019
2	AndrogensIBA 01/2020 - 10/2004
2	Proteoglycans (Proteoglycan)IBA 01/2020 - 01/2020
2	Protein Isoforms (Isoforms)IBA 10/2019 - 01/2008
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 09/2018 - 05/2018
2	Capecitabine (Xeloda)FDA Link 09/2018 - 01/2013
2	Fluorouracil (Carac)FDA LinkGeneric 09/2018 - 05/2018
2	Phenobarbital (Luminal)FDA Link 01/2018 - 01/2016
2	CaveolinsIBA 02/2017 - 10/2015
2	Peptides (Polypeptides)IBA 10/2016 - 11/2012
2	IntegrinsIBA 11/2012 - 04/2011
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2009 - 02/2003
2	SteroidsIBA 04/2006 - 10/2003
2	Oxytocin Receptors (Oxytocin Receptor)IBA 07/2005 - 10/2004
2	SecretagoguesIBA 02/2004 - 02/2002
2	Estrogen Receptor alphaIBA 10/2003 - 08/2002
1	Immunoglobulin G (IgG)IBA 03/2022
1	Calcibiotic Root Canal SealerIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	InterferonsIBA 12/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	1-methyl-1-piperidinomethane sulfonateIBA 01/2021
1	Volatile Fatty AcidsIBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Lapatinib (GW572016)FDA Link 01/2021
1	pertuzumabIBA 01/2021

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 01/2022 - 05/2012
15	Radiotherapy 01/2021 - 01/2013
12	Therapeutics 01/2021 - 06/2009
6	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 05/2021 - 07/2015
3	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 01/2020
3	Immunotherapy 08/2020 - 08/2019
2	Cesarean Section (Caesarean Section) 10/2021 - 04/2014
2	Combined Modality Therapy 06/2021 - 06/2017
2	Lasers (Laser) 05/2017 - 03/2012
2	Neoadjuvant Therapy 06/2015 - 01/2015
1	Colectomy 01/2022